When did entresto go generic?

Entresto (sacubitril/valsartan) has not yet gone generic [1]. The drug is currently under patent protection, with its primary patents expected to expire in the coming years [1].

When does Entresto's patent expire?

The key patents protecting Entresto are slated to expire in 2025 and 2027 [1]. However, the exact timeline for generic availability can be influenced by various factors, including potential patent challenges and regulatory reviews [2].

Can a generic version of Entresto be available now?

No, a generic version of Entresto is not currently available [1]. The drug remains under patent protection until the expiration dates mentioned above [1].

What happens after Entresto's patents expire?

Once the patents expire and any associated exclusivity periods conclude, pharmaceutical companies will be able to apply to the U.S. Food and Drug Administration (FDA) for approval to market generic versions of Entresto [2]. This would likely lead to increased competition and potentially lower prices for the medication [3].

Who makes Entresto?

Entresto is manufactured by Novartis [4].